Eli Lilly agreed to acquire Bothell, Wash.-based Curevo Vaccine for up to $1.5 billion in cash. The deal centers on a next-generation shingles vaccine that reduced side effects by more than half in a Phase 2 study. Read More
Bill Gates and his foundation are raising the alarm over the impacts of international funding cuts for global health, including an increase in children’s deaths. Read More
Seattle-based biotech startup Icosavax today scored $51 million in funding to create vaccines from artificial viruses. The Series A financing… Read More